iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
2.420
+0.270 (12.56%)
At close: Feb 6, 2026, 4:00 PM EST
2.454
+0.034 (1.40%)
After-hours: Feb 6, 2026, 7:59 PM EST
iBio, Inc. Employees
iBio, Inc. had 20 employees as of June 30, 2025. The number of employees increased by 4 or 25.00% compared to the previous year.
Employees
20
Change (1Y)
4
Growth (1Y)
25.00%
Revenue / Employee
$25,000
Profits / Employee
-$1,005,400
Market Cap
78.75M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2025 | 20 | 4 | 25.00% | 20 | 0 |
| Jun 30, 2024 | 16 | -10 | -38.46% | 16 | 0 |
| Jun 30, 2023 | 26 | -80 | -75.47% | 26 | 0 |
| Jun 30, 2022 | 106 | 31 | 41.33% | 105 | 1 |
| Jun 30, 2021 | 75 | 24 | 47.06% | 49 | 26 |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Adicet Bio | 152 |
| MindWalk Holdings | 102 |
| Immunic | 90 |
| XBiotech | 88 |
| PolyPid | 60 |
| Biomea Fusion | 42 |
| MediciNova | 13 |
| MAIA Biotechnology | 13 |
IBIO News
- 4 weeks ago - iBio Announces $26 Million Private Placement - GlobeNewsWire
- 2 months ago - iBio to Participate in the 8th Annual Evercore Healthcare Conference - GlobeNewsWire
- 3 months ago - iBio Reports Q1 Fiscal Year 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 3 months ago - iBio Unveils New Non-Human Primate Data on IBIO-610, an Activin E Antibody with Strong Therapeutic Potential for Fat-Selective Weight-Loss and Weight Maintenance - GlobeNewsWire
- 3 months ago - iBio to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference - GlobeNewsWire
- 3 months ago - iBio to Present New Preclinical Data on Its Activin E Antibody at Two Upcoming Scientific Conferences, ObesityWeek® and PEGS Europe 2025 - GlobeNewsWire
- 5 months ago - iBio Reports Fiscal Year 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 5 months ago - iBio Announces Closing of $50 Million Public Offering - GlobeNewsWire